Making HIV trial and patient data more reliable
Improved Analyses of Randomized and Nonrandomized HIV Studies
This project creates and shares new methods to combine information from different HIV clinical trials and patient studies so people living with HIV get clearer answers about treatments and prevention.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11327933 on NIH RePORTER |
What this research studies
Researchers are developing "fusion" methods that combine randomized trial data and observational study data to make results more accurate and reliable. They will build techniques that leverage detailed data from subsets of participants and that pool external datasets from multiple trials and cohorts. The team will validate these approaches using existing HIV trial and observational datasets and publish software and guides so other researchers can apply them. From your perspective, this means experts are working behind the scenes on better ways to use past patient data so future care decisions can be based on stronger evidence.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV whose clinical trial or observational data could be included in pooled analyses, or former trial participants willing to have their data used.
Not a fit: People who do not have HIV or whose health records are not part of the combined datasets would not directly benefit from this work.
Why it matters
Potential benefit: If successful, these methods could give clinicians and people with HIV more trustworthy evidence about which treatments and prevention strategies work best.
How similar studies have performed: Traditional meta-analyses have improved precision in HIV research, but fusion methods that combine dissimilar trials and observational studies are newer and still under development.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Cole, Stephen R — Univ of North Carolina Chapel Hill
- Study coordinator: Cole, Stephen R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.